Kiromic BioPharma, Inc. (KRBPQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Oct 5, 2026
Kiromic BioPharma Market Cap
Kiromic BioPharma has a market cap or net worth of $157 as of October 9, 2026. It is the 52,769th most valuable company in the world and the 8,794th biggest in the United States. Its market cap has decreased by 97.50% in one year.
Market Cap
157.00
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#8,794 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since October 16, 2020, Kiromic BioPharma's market cap has decreased from 84.33M to 157.00, a decrease of -100.00%. That is a compound annual growth rate of -89.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 2.00 | - |
| Dec 30, 2025 | 2.00 | -100.00% |
| Dec 31, 2024 | 1.38M | 26.04% |
| Dec 29, 2023 | 1.09M | -66.79% |
| Dec 30, 2022 | 3.30M | -86.04% |
| Dec 31, 2021 | 23.62M | -61.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sirona Biochem | 266.00 |
| Nanobac Pharmaceuticals | 250.00 |
| Regenicin | 153.00 |
| Poniard Pharmaceuticals | 150.00 |
| NexImmune | 139.00 |
| Seelos Therapeutics | 136.00 |
| PsyBio Therapeutics | 133.00 |
| Marizyme | 132.00 |